Cholesterol kinetics in subjects with bile fistula. Positive relationship between size of the bile acid precursor pool and bile acid synthetic rate
Our aim was to identify and quantitate cholesterol pools and transport pathways in blood and liver. By studying bile fistula subjects, using several types of isotopic preparations, simultaneous labeling of separate cholesterol pools and sampling all components of blood and bile at frequent intervals...
Saved in:
Published in | The Journal of clinical investigation Vol. 91; no. 3; pp. 923 - 938 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Ann Arbor, MI
American Society for Clinical Investigation
01.03.1993
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Our aim was to identify and quantitate cholesterol pools and transport pathways in blood and liver. By studying bile fistula subjects, using several types of isotopic preparations, simultaneous labeling of separate cholesterol pools and sampling all components of blood and bile at frequent intervals, we developed a comprehensive multicompartmental model for cholesterol within the rapidly miscible pool. Data in six components (bile acids, esterified cholesterol in whole plasma, and free cholesterol in blood cells, bile, alpha lipoproteins, and beta lipoproteins) were modeled simultaneously with the SAAM program. The analysis revealed extensive exchange of free cholesterol between HDL and liver, blood cells, and other tissues. There was net free cholesterol transport from HDL to the liver in most subjects. The major organ that removed esterified cholesterol from blood was the liver. A large portion (4,211 mumol) of total hepatic cholesterol comprised a pool that turned over rapidly (t1/2 of 72 min) by exchanging mainly with plasma HDL and was the major source of bile acids and biliary cholesterol. Only 6% of hepatic newly synthesized cholesterol was used directly for bile acid synthesis: the analysis showed that 94% of newly synthesized cholesterol was partitioned into the large hepatic pool (putative plasma membrane free cholesterol) which exchanged rapidly with plasma lipoproteins. Bile acid synthetic rate correlated directly with the size of the large hepatic pool. In conclusion, hepatic and blood cholesterol pools and transports have been quantitated. HDL plays a central role in free cholesterol exchange/transport between all tissues and plasma. In humans, the metabolically active pool comprises a large portion of total hepatic cholesterol that, in part, regulates bile acid synthesis. |
---|---|
AbstractList | Our aim was to identify and quantitate cholesterol pools and transport pathways in blood and liver. By studying bile fistula subjects, using several types of isotopic preparations, simultaneous labeling of separate cholesterol pools and sampling all components of blood and bile at frequent intervals, we developed a comprehensive multicompartmental model for cholesterol within the rapidly miscible pool. Data in six components (bile acids, esterified cholesterol in whole plasma, and free cholesterol in blood cells, bile, alpha lipoproteins, and beta lipoproteins) were modeled simultaneously with the SAAM program. The analysis revealed extensive exchange of free cholesterol between HDL and liver, blood cells, and other tissues. There was net free cholesterol transport from HDL to the liver in most subjects. The major organ that removed esterified cholesterol from blood was the liver. A large portion (4,211 mumol) of total hepatic cholesterol comprised a pool that turned over rapidly (t1/2 of 72 min) by exchanging mainly with plasma HDL and was the major source of bile acids and biliary cholesterol. Only 6% of hepatic newly synthesized cholesterol was used directly for bile acid synthesis: the analysis showed that 94% of newly synthesized cholesterol was partitioned into the large hepatic pool (putative plasma membrane free cholesterol) which exchanged rapidly with plasma lipoproteins. Bile acid synthetic rate correlated directly with the size of the large hepatic pool. In conclusion, hepatic and blood cholesterol pools and transports have been quantitated. HDL plays a central role in free cholesterol exchange/transport between all tissues and plasma. In humans, the metabolically active pool comprises a large portion of total hepatic cholesterol that, in part, regulates bile acid synthesis. Our aim was to identify and quantitate cholesterol pools and transport pathways in blood and liver. By studying bile fistula subjects, using several types of isotopic preparations, simultaneous labeling of separate cholesterol pools and sampling all components of blood and bile at frequent intervals, we developed a comprehensive multicompartmental model for cholesterol within the rapidly miscible pool. Data in six components (bile acids, esterified cholesterol in whole plasma, and free cholesterol in blood cells, bile, alpha lipoproteins, and beta lipoproteins) were modeled simultaneously with the SAAM program. The analysis revealed extensive exchange of free cholesterol between HDL and liver, blood cells, and other tissues. There was net free cholesterol transport from HDL to the liver in most subjects. The major organ that removed esterified cholesterol from blood was the liver. A large portion (4,211 mumol) of total hepatic cholesterol comprised a pool that turned over rapidly (t1/2 of 72 min) by exchanging mainly with plasma HDL and was the major source of bile acids and biliary cholesterol. Only 6% of hepatic newly synthesized cholesterol was used directly for bile acid synthesis: the analysis showed that 94% of newly synthesized cholesterol was partitioned into the large hepatic pool (putative plasma membrane free cholesterol) which exchanged rapidly with plasma lipoproteins. Bile acid synthetic rate correlated directly with the size of the large hepatic pool. In conclusion, hepatic and blood cholesterol pools and transports have been quantitated. HDL plays a central role in free cholesterol exchange/transport between all tissues and plasma. In humans, the metabolically active pool comprises a large portion of total hepatic cholesterol that, in part, regulates bile acid synthesis.Our aim was to identify and quantitate cholesterol pools and transport pathways in blood and liver. By studying bile fistula subjects, using several types of isotopic preparations, simultaneous labeling of separate cholesterol pools and sampling all components of blood and bile at frequent intervals, we developed a comprehensive multicompartmental model for cholesterol within the rapidly miscible pool. Data in six components (bile acids, esterified cholesterol in whole plasma, and free cholesterol in blood cells, bile, alpha lipoproteins, and beta lipoproteins) were modeled simultaneously with the SAAM program. The analysis revealed extensive exchange of free cholesterol between HDL and liver, blood cells, and other tissues. There was net free cholesterol transport from HDL to the liver in most subjects. The major organ that removed esterified cholesterol from blood was the liver. A large portion (4,211 mumol) of total hepatic cholesterol comprised a pool that turned over rapidly (t1/2 of 72 min) by exchanging mainly with plasma HDL and was the major source of bile acids and biliary cholesterol. Only 6% of hepatic newly synthesized cholesterol was used directly for bile acid synthesis: the analysis showed that 94% of newly synthesized cholesterol was partitioned into the large hepatic pool (putative plasma membrane free cholesterol) which exchanged rapidly with plasma lipoproteins. Bile acid synthetic rate correlated directly with the size of the large hepatic pool. In conclusion, hepatic and blood cholesterol pools and transports have been quantitated. HDL plays a central role in free cholesterol exchange/transport between all tissues and plasma. In humans, the metabolically active pool comprises a large portion of total hepatic cholesterol that, in part, regulates bile acid synthesis. |
Author | Cooper, P S Zech, L A VandenBroek, J M Schwartz, C C |
AuthorAffiliation | Department of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298 |
AuthorAffiliation_xml | – name: Department of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298 |
Author_xml | – sequence: 1 givenname: C C surname: Schwartz fullname: Schwartz, C C – sequence: 2 givenname: L A surname: Zech fullname: Zech, L A – sequence: 3 givenname: J M surname: VandenBroek fullname: VandenBroek, J M – sequence: 4 givenname: P S surname: Cooper fullname: Cooper, P S |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4681188$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/8450070$$D View this record in MEDLINE/PubMed |
BookMark | eNptkc1u1DAUhb0oKv1hwQMgeYGQWExrJ3biLFigEYWiSrCAdeQ41-QWjx1sp1X7GrwwLjMatQjdxV2c79wj-xyTAx88EPKSszPO2-r88_qS86bm4oAcMVbxVdfW6jk5TumaMS6EFIfkUAnJWMuOyO_1FBykDDE4-hM9ZDSJoqdpGa7B5ERvMU90QAfUYsqL02f0a0iY8QZoBKczBp8mnOkA-RagOPEeaLA0T7D1aYMjnSOYJaYQ6RxKlPbjIzHd-UKXaBp1hlPyzGqX4MVun5DvFx--rT-trr58vFy_v1qZulN5JTljRlSysWVZ2VWsG-XARys6zipoBGstNAbUOPBGSaFrbR8cUtmqAiXqE_Jue3dehg2MBnyO2vVzxI2Od33Q2D9VPE79j3DTV0oxIYv_zc4fw6-lfGK_wWTAOe0hLKlvZSPaMgV89Thon7Broeivd7pORjsbtTeY9phoFOdKFeztFjMxpBTB7gnO-ofu-333hT3_hzWY_3ZVXoLuP44_ULO1dA |
CODEN | JCINAO |
CitedBy_id | crossref_primary_10_1007_s11745_000_0616_9 crossref_primary_10_1016_S0022_2275_20_33323_X crossref_primary_10_1161_ATVBAHA_112_252932 crossref_primary_10_1016_j_bbalip_2021_159058 crossref_primary_10_1016_S0022_2275_20_37426_5 crossref_primary_10_1194_jlr_P028449 crossref_primary_10_1542_peds_2004_0997 crossref_primary_10_1016_S0022_2275_20_30027_4 crossref_primary_10_1194_jlr_M043067 crossref_primary_10_1007_s11745_005_1437_6 crossref_primary_10_1016_S0022_2275_20_39758_3 crossref_primary_10_1016_S0022_2275_20_33881_5 crossref_primary_10_1093_jn_127_2_332 crossref_primary_10_1093_ajcn_66_2_438 crossref_primary_10_3390_biology8030053 crossref_primary_10_1016_S0022_2275_20_40105_1 crossref_primary_10_1093_ajcn_73_5_870 crossref_primary_10_1016_0163_7827_94_00007_9 crossref_primary_10_1016_S0022_2275_20_37453_8 crossref_primary_10_1194_jlr_M300511_JLR200 crossref_primary_10_1093_hmg_ddn278 crossref_primary_10_1016_S0021_9150_98_00223_8 crossref_primary_10_1007_s11883_004_0052_3 crossref_primary_10_1097_MOL_0000000000000050 crossref_primary_10_1152_ajpendo_1996_271_6_E1073 crossref_primary_10_1194_jlr_M075226 crossref_primary_10_1097_MEG_0000000000000803 crossref_primary_10_1194_jlr_M048629 crossref_primary_10_1093_ajcn_78_2_339 crossref_primary_10_1093_jn_124_5_717 crossref_primary_10_1016_S0955_2863_98_00059_X crossref_primary_10_1161_01_ATV_0000201064_89581_35 crossref_primary_10_1097_MOL_0000000000000475 crossref_primary_10_1111_j_1530_0277_1999_tb04191_x crossref_primary_10_1021_jf070145q crossref_primary_10_1016_j_jacl_2013_08_001 crossref_primary_10_1161_01_ATV_16_10_1222 crossref_primary_10_1073_pnas_100114397 crossref_primary_10_1161_atvb_21_11_1707 crossref_primary_10_1079_BJN19960148 crossref_primary_10_1016_j_atherosclerosis_2013_08_006 crossref_primary_10_1016_j_atherosclerosis_2019_09_022 crossref_primary_10_1203_00006450_199807000_00010 crossref_primary_10_1016_j_molmed_2020_07_005 crossref_primary_10_1016_S0022_2275_20_41201_5 crossref_primary_10_1161_JAHA_112_001826 |
ContentType | Journal Article |
Copyright | 1993 INIST-CNRS |
Copyright_xml | – notice: 1993 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1172/JCI116314 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EndPage | 938 |
ExternalDocumentID | PMC288045 8450070 4681188 10_1172_JCI116314 |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: P01-DK38030 – fundername: NIADDK NIH HHS grantid: AM25920 – fundername: NCRR NIH HHS grantid: RR00065 |
GroupedDBID | --- -~X .55 .GJ .XZ 08P 29K 2WC 354 3O- 53G 5GY 5RE 5RS 8F7 AAWTL AAYXX ABOCM ABPMR ACGFO ACIHN ACNCT ACPRK ADBBV AEAQA AENEX AFCHL AFFNX AHMBA AI. ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS ASPBG AVWKF AZFZN BAWUL CITATION CS3 D-I DIK DU5 E3Z EBS EJD EMB F5P FRP GROUPED_DOAJ GX1 HYE H~9 IAO IEA IHR INH IOF IPO J5H KQ8 L7B M1P M5~ MVM N4W OBH OCB ODZKP OFXIZ OGEVE OHH OK1 OVD OVIDX OVT P2P P6G RPM TEORI TR2 TVE UHU VH1 VVN W2D WH7 WOQ WOW X7M YFH YOC ZGI ZXP ZY1 ~H1 08G 36B 7RV 7X7 88E 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 AAKAS ABUWG ADZCM AFKRA BBNVY BCR BCU BEC BENPR BHPHI BKEYQ BLC BPHCQ BVXVI CCPQU EBD EMOBN EX3 FEDTE FYUFA HCIFZ HMCUK HVGLF IHW IOV IQODW ISR ITC LK8 M7P NAPCQ OHT PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO Q2X S0X SJFOW SV3 UKHRP XSB YHG YKV 3V. 88A AAYOK CGR CUY CVF ECM EIF INR M0L NPM PKN 7X8 5PM |
ID | FETCH-LOGICAL-c398t-5100c4256f0c4f59209d5b1df49102e6407fe6ce8db16854a3af00c458f22e843 |
ISSN | 0021-9738 |
IngestDate | Thu Aug 21 13:56:50 EDT 2025 Fri Jul 11 02:59:02 EDT 2025 Wed Feb 19 01:17:42 EST 2025 Mon Jul 21 09:16:30 EDT 2025 Thu Apr 24 22:55:55 EDT 2025 Tue Jul 01 01:43:41 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Human Biliary tract Digestive diseases Exploration Fistula Biliary tract disease Metabolism Cholesterol |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c398t-5100c4256f0c4f59209d5b1df49102e6407fe6ce8db16854a3af00c458f22e843 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://www.jci.org/articles/view/116314/files/pdf |
PMID | 8450070 |
PQID | 75647474 |
PQPubID | 23479 |
PageCount | 16 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_288045 proquest_miscellaneous_75647474 pubmed_primary_8450070 pascalfrancis_primary_4681188 crossref_primary_10_1172_JCI116314 crossref_citationtrail_10_1172_JCI116314 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 1993-03-01 |
PublicationDateYYYYMMDD | 1993-03-01 |
PublicationDate_xml | – month: 03 year: 1993 text: 1993-03-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Ann Arbor, MI |
PublicationPlace_xml | – name: Ann Arbor, MI – name: United States |
PublicationTitle | The Journal of clinical investigation |
PublicationTitleAlternate | J Clin Invest |
PublicationYear | 1993 |
Publisher | American Society for Clinical Investigation |
Publisher_xml | – name: American Society for Clinical Investigation |
References | 14794694 - J Biol Chem. 1950 Nov;187(1):97-106 13563493 - J Biol Chem. 1958 Aug;233(2):311-20 20 1245596 - J Clin Invest. 1976 Jan;57(1):137-48 13252315 - J Lab Clin Med. 1955 Sep;46(3):372-84 4371482 - Adv Lipid Res. 1973;11(0):67-108 2090713 - J Lipid Res. 1990 Dec;31(12):2195-200 13755282 - J Lab Clin Med. 1961 Apr;57:574-85 6953075 - J Clin Invest. 1982 Jul;70(1):105-16 7119117 - J Clin Invest. 1982 Oct;70(4):863-76 2153669 - J Biol Chem. 1990 Feb 5;265(4):1919-23 5411785 - J Clin Invest. 1970 Feb;49(2):346-57 5059197 - J Lipid Res. 1972 Jan;13(1):32-8 6418742 - J Biol Chem. 1983 Dec 25;258(24):15130-4 2335522 - J Biol Chem. 1990 May 15;265(14):8190-7 4698266 - J Lipid Res. 1973 Mar;14(2):178-88 928398 - Proc Soc Exp Biol Med. 1977 Nov;156(2):261-4 13699354 - Circulation. 1960 Oct;22:547-58 13428781 - J Biol Chem. 1957 May;226(1):497-509 3367083 - J Lipid Res. 1988 Feb;29(2):136-43 4336943 - J Clin Invest. 1972 Jun;51(6):1528-36 13221654 - J Clin Invest. 1955 Jan;34(1):48-60 621281 - J Clin Invest. 1978 Feb;61(2):408-23 2999124 - J Biol Chem. 1985 Dec 15;260(29):15592-7 3700371 - J Biol Chem. 1986 May 5;261(13):5766-76 197124 - J Clin Invest. 1977 Oct;60(4):795-807 1569382 - J Lipid Res. 1992 Mar;33(3):315-21 204996 - Science. 1978 Apr 7;200(4337):62-4 6392459 - J Lipid Res. 1984 Oct;25(10):1017-58 4176473 - J Lipid Res. 1968 Nov;9(6):693-700 |
References_xml | – reference: 7119117 - J Clin Invest. 1982 Oct;70(4):863-76 – reference: 13252315 - J Lab Clin Med. 1955 Sep;46(3):372-84 – reference: 5059197 - J Lipid Res. 1972 Jan;13(1):32-8 – reference: 14794694 - J Biol Chem. 1950 Nov;187(1):97-106 – reference: 4698266 - J Lipid Res. 1973 Mar;14(2):178-88 – reference: 2335522 - J Biol Chem. 1990 May 15;265(14):8190-7 – reference: 13428781 - J Biol Chem. 1957 May;226(1):497-509 – reference: 5411785 - J Clin Invest. 1970 Feb;49(2):346-57 – reference: 6953075 - J Clin Invest. 1982 Jul;70(1):105-16 – reference: 4336943 - J Clin Invest. 1972 Jun;51(6):1528-36 – reference: 13755282 - J Lab Clin Med. 1961 Apr;57:574-85 – reference: 3367083 - J Lipid Res. 1988 Feb;29(2):136-43 – reference: 3700371 - J Biol Chem. 1986 May 5;261(13):5766-76 – reference: 2090713 - J Lipid Res. 1990 Dec;31(12):2195-200 – reference: 13563493 - J Biol Chem. 1958 Aug;233(2):311-20 20 – reference: 928398 - Proc Soc Exp Biol Med. 1977 Nov;156(2):261-4 – reference: 6392459 - J Lipid Res. 1984 Oct;25(10):1017-58 – reference: 2153669 - J Biol Chem. 1990 Feb 5;265(4):1919-23 – reference: 13699354 - Circulation. 1960 Oct;22:547-58 – reference: 13221654 - J Clin Invest. 1955 Jan;34(1):48-60 – reference: 4371482 - Adv Lipid Res. 1973;11(0):67-108 – reference: 4176473 - J Lipid Res. 1968 Nov;9(6):693-700 – reference: 197124 - J Clin Invest. 1977 Oct;60(4):795-807 – reference: 204996 - Science. 1978 Apr 7;200(4337):62-4 – reference: 1569382 - J Lipid Res. 1992 Mar;33(3):315-21 – reference: 1245596 - J Clin Invest. 1976 Jan;57(1):137-48 – reference: 621281 - J Clin Invest. 1978 Feb;61(2):408-23 – reference: 2999124 - J Biol Chem. 1985 Dec 15;260(29):15592-7 – reference: 6418742 - J Biol Chem. 1983 Dec 25;258(24):15130-4 |
SSID | ssj0014454 |
Score | 1.6286141 |
Snippet | Our aim was to identify and quantitate cholesterol pools and transport pathways in blood and liver. By studying bile fistula subjects, using several types of... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 923 |
SubjectTerms | Bile - metabolism Bile - secretion Bile Acids and Salts - metabolism Biliary Fistula - blood Biliary Fistula - metabolism Biliary Fistula - surgery Biological and medical sciences Carbon Radioisotopes Cholecystectomy Cholesterol - blood Cholesterol - metabolism Gastroenterology. Liver. Pancreas. Abdomen Humans Lipoproteins - blood Liver - metabolism Liver. Biliary tract. Portal circulation. Exocrine pancreas Medical sciences Mevalonic Acid - metabolism Models, Biological Other diseases. Semiology Radioisotope Dilution Technique Tritium |
Title | Cholesterol kinetics in subjects with bile fistula. Positive relationship between size of the bile acid precursor pool and bile acid synthetic rate |
URI | https://www.ncbi.nlm.nih.gov/pubmed/8450070 https://www.proquest.com/docview/75647474 https://pubmed.ncbi.nlm.nih.gov/PMC288045 |
Volume | 91 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbKkBASQvxNKzCwEBdIVUYSO4lzCRVoKwwhsaGJm8pJbC1QJVWTCLHX4CV4TI7txEm2Xgxu0ir2idKeLzk_PuczQi9DQfxYculwwqhDhfScOPW5E4L1oCkJ3YSrQPH4U3h4Shdnwdlk8mdQtdTUyUF6sbWv5H-0CudAr6pL9h80ay8KJ-A76BeOoGE4XkvHc7W5rWI6KFezH-AuasrlvJhVTfJdV2noLGsCD_5MgjqbFT9Qu_OacqFNVwY3LNeq8gtbNqDleJprIoG0Ac98M1M7cun1hn6w-lXAbE0FzetRYVHfdqYdXtuEmffcHn0RwJf0_Cf8RJ3PHuRuvwmzV9XHPun6VeW9i7ebUug3-aJP6M7Lcm0g-LlN6WZtgx_pC7psfwHgJTKcL907OvYGWCSDF25supVb2x0bqatmIVI0s4v5kQfup2laHVNvXzKJtlBRh0iRv7SiN9BNHwISHbwffbDrVZQGLd-3ufeWwwpEX1vRkedzZ80r-Mel2T1lW3hzuUp34Pac3EN3W_XhNwZ899FEFA_QreO2IuMh-j3AIO4wiPMCdxjECoNYwQV3GMQdBvEQg7jFIFYYxKXEgCojp2CGLQaxwiAGDAwGLQaxwuAjdPr-3cn80Gk3-nBSErPaAbvgpmA8QgkfMoh9N86CxMskBWfWF2qtWYowFSxLvJAFlBMulUTApO8LRsku2inKQuwhnLlSSEZYxDMBsUGU8FhQSYkrsgTUxqfoVaeEZdqy4KvNWFbLK6qeohd26tpQv2ybtD_SpJ1JQwaxO5ui551ml_DiVqtxvBBlUy2jIKQQy8MVdo2erSijgWLhmqJwBAA7rhjhxyNFfq6Z4X2wxjR4fJ0bf4Ju90_fU7RTbxqxD_51nTzT0P4Lq2rYWg |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cholesterol+kinetics+in+subjects+with+bile+fistula.+Positive+relationship+between+size+of+the+bile+acid+precursor+pool+and+bile+acid+synthetic+rate&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Schwartz%2C+C+C&rft.au=Zech%2C+L+A&rft.au=VandenBroek%2C+J+M&rft.au=Cooper%2C+P+S&rft.date=1993-03-01&rft.issn=0021-9738&rft.volume=91&rft.issue=3&rft.spage=923&rft.epage=938&rft_id=info:doi/10.1172%2FJCI116314&rft.externalDBID=n%2Fa&rft.externalDocID=10_1172_JCI116314 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9738&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9738&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9738&client=summon |